Biohaven Pharmaceutical Holding Co (BHVN) Financials

$12.71

$-0.08 (-0.63%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,920 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

158.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-609.44	-582.45	-331.73	-297.69	-145.84
Cash Flow from Investing Activities	--	300.56	-244.97	129.83	-304.79	0.94
Cash from Financing Activities	--	439.12	677.77	211.91	767.60	138.45
Net Cash Inflow / Outflow	--	--	--	--	--	40.30

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.65	-6.15	-8.38	-5.11	-9.37	-5.43
Cash EPS ($)	--	-6.06	-8.30	-5.02	-9.35	-5.40
Adjusted Book Value ($)	--	0.43	4.19	5.35	8.85	2.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.07	-5.76	-4.15	-4.89	-3.70
Free Cash Flow per Share ($)	--	-5.08	-5.80	-4.19	-5.57	-3.73

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-185.47	-184.23	-79.16	-88.13	-40.11
ROE (%)	-1,825.49	-310.75	-198.83	-84.44	-180.05	-249.37
ROA (%)	-87.46	-138.54	-150.03	-69.48	-141.89	-168.64
EBIT Margin (%)	--	--	--	--	--	-45.93
Net Margin (%)	--	--	--	--	--	-53.84
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	-1.00	--
EBIT Growth (%)	23.56	12.81	-106.49	28.13	-168.25	-85.52
Net Profit Growth (%)	23.49	12.71	-107.37	28.43	-166.74	-80.16
EPS Growth (%)	39.33	0.27	-0.64	0.46	-0.73	-1.22
Book Value Growth (%)	-93.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.84	-4.46	-8.38	-1.48	-25.38
Price / Book Value	158.06	26.06	8.91	7.99	1.57	57.29
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.19	-1.82	-3.97	-7.62	-0.73	-27.41
Close Price ($)	14.88	11.29	37.35	42.80	13.88	137.81
High Price ($)	18.57	44.28	62.21	44.21	151.50	151.51
Low Price ($)	7.48	7.48	26.80	12.35	5.54	62.57
Market Cap ($ Cr)	1,919.77	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	5.47	0.09	0.07	0.06	6.62
Short term debt to equity ratio	0.38	0.11	0.01	0.01	0.01	0.00
Current Ratio	4.73	3.18	3.49	7.98	6.52	2.26
Quick Ratio	4.73	--	--	7.99	5.90	2.10
Interest Coverage	--	--	--	--	-411.14	-5.11

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	2.14
Asset Turnover	--	--	--	--	--	3.65
Receivable days	--	--	--	--	--	51.34
Inventory Days	--	--	-36.87	3,022.66	8,286.77	6,069.63
Payable days	--	1,308.90	1,564.44	1,424.57	2,039.44	987.59
Cash Conversion Cycle	--	--	--	--	--	5,133.38

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.